CIR Panel's Parabens Review Leaning Toward Safe, But 'Insufficient Data' For Now

Cosmetic Ingredient Review’s independent experts will continue to mull new safety information for parabens, as well as input from a P&G expert, but the panel is inclined to determine the preservatives safe as used in an assessment that could differ “significantly” from European conclusions. 

The Cosmetic Ingredient Review Expert Panel’s re-review of parabens’ safety remains in the draft stage due to insufficient data, though panelists indicated March 6 that they’re inclined to affirm the ingredients safe as used.

That’s certainly the outcome awaited by US industry, which continues to rely heavily on parabens for their broad-spectrum antimicrobial clout,...

More from Ingredients & Safety

More from HBW Insight

‘Off-Label’ Beauty Hacks: Navigating the Risks of Consumer-Driven Innovation

 
• By 

Guest authors Rachel Raphael, partner at Morgan, Lewis & Bockius, LLP and associates at the firm, Elizabeth Bresnahan and Kathryn Ignash, advise beauty companies on how to navigate the legal risks associated with consumers ‘off-label’ beauty hacks.

Danone Acquires Belgian Firm Marketing Gut Health Supplement in US

 
• By 

Danone moves into dietary supplements space with deal for The Akkermansia Company marketing patented biotic strain in US, Europe and Asia.

US Adverse Event Report Forms Replace ‘Gender’ Options With Male Or Female ‘Sex’ Question

Modifications to forms FDA 3500, for voluntary reporting by healthcare professionals, and 3500A, for mandatory reporting by manufacturers, marketers or facilities, include limiting changing gender question to sex and asking for only male or female answer.